Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment.

National Research Council (US) Committee on Applications of Toxicogenomic Technologies to Predictive Toxicology.

Washington (DC): National Academies Press (US); 2007.

2.

Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.

Thybaud V, Aardema M, Clements J, Dearfield K, Galloway S, Hayashi M, Jacobson-Kram D, Kirkland D, MacGregor JT, Marzin D, Ohyama W, Schuler M, Suzuki H, Zeiger E; Expert Working Group on Hazard Identification and Risk Assessment in Relation to In Vitro Testing..

Mutat Res. 2007 Feb 3;627(1):41-58. Epub 2006 Nov 27.

PMID:
17126066
3.

Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.

Heijne WH, Kienhuis AS, van Ommen B, Stierum RH, Groten JP.

Expert Rev Proteomics. 2005 Oct;2(5):767-80. Review.

PMID:
16209655
4.

Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment.

Wilson VS, Keshava N, Hester S, Segal D, Chiu W, Thompson CM, Euling SY.

Toxicol Appl Pharmacol. 2013 Sep 15;271(3):299-308. doi: 10.1016/j.taap.2011.01.017. Epub 2011 Feb 2. Review.

PMID:
21295051
5.

Toxicogenomics in the assessment of immunotoxicity.

Baken KA, Vandebriel RJ, Pennings JL, Kleinjans JC, van Loveren H.

Methods. 2007 Jan;41(1):132-41. Review.

PMID:
17161310
6.

Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.

Dearfield KL, Gollapudi BB, Bemis JC, Benz RD, Douglas GR, Elespuru RK, Johnson GE, Kirkland DJ, LeBaron MJ, Li AP, Marchetti F, Pottenger LH, Rorije E, Tanir JY, Thybaud V, van Benthem J, Yauk CL, Zeiger E, Luijten M.

Environ Mol Mutagen. 2016 Sep 21. doi: 10.1002/em.22045. [Epub ahead of print] Review.

PMID:
27650663
7.

Screening tests for hazard classification of complex waste materials--selection of methods.

Weltens R, Vanermen G, Tirez K, Robbens J, Deprez K, Michiels L.

Waste Manag. 2012 Dec;32(12):2208-17. doi: 10.1016/j.wasman.2012.05.013. Epub 2012 Aug 21.

PMID:
22917872
8.

The zebrafish embryo model in environmental risk assessment--applications beyond acute toxicity testing.

Scholz S, Fischer S, Gündel U, Küster E, Luckenbach T, Voelker D.

Environ Sci Pollut Res Int. 2008 Jul;15(5):394-404. doi: 10.1007/s11356-008-0018-z. Epub 2008 Jun 25. Review.

PMID:
18575912
9.

Integrating toxicogenomics into human health risk assessment: lessons learned from the benzo[a]pyrene case study.

Chepelev NL, Moffat ID, Labib S, Bourdon-Lacombe J, Kuo B, Buick JK, Lemieux F, Malik AI, Halappanavar S, Williams A, Yauk CL.

Crit Rev Toxicol. 2015 Jan;45(1):44-52. doi: 10.3109/10408444.2014.973935. Review.

PMID:
25605027
10.

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.

11.

Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.

Bushnell PJ, Kavlock RJ, Crofton KM, Weiss B, Rice DC.

Neurotoxicol Teratol. 2010 May-Jun;32(3):313-28. doi: 10.1016/j.ntt.2010.02.002. Epub 2010 Feb 17.

PMID:
20171276
12.

Toxicogenomics in risk assessment: applications and needs.

Boverhof DR, Zacharewski TR.

Toxicol Sci. 2006 Feb;89(2):352-60. Epub 2005 Oct 12. Review.

PMID:
16221963
13.

Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force [Internet].

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan.

14.

DNA microarrays and toxicogenomics: applications for ecotoxicology?

Neumann NF, Galvez F.

Biotechnol Adv. 2002 Dec;20(5-6):391-419.

PMID:
14550024
15.

Toxicogenomics: the challenges and opportunities to identify biomarkers, signatures and thresholds to support mode-of-action.

Currie RA.

Mutat Res. 2012 Aug 15;746(2):97-103. doi: 10.1016/j.mrgentox.2012.03.002. Epub 2012 Mar 13.

PMID:
22445948
16.

Integrated testing and intelligent assessment-new challenges under REACH.

Ahlers J, Stock F, Werschkun B.

Environ Sci Pollut Res Int. 2008 Oct;15(7):565-72. doi: 10.1007/s11356-008-0043-y. Epub 2008 Sep 26.

PMID:
18818964
17.

American Medical Society for Sports Medicine position statement: concussion in sport.

Harmon KG, Drezner JA, Gammons M, Guskiewicz KM, Halstead M, Herring SA, Kutcher JS, Pana A, Putukian M, Roberts WO.

Br J Sports Med. 2013 Jan;47(1):15-26. doi: 10.1136/bjsports-2012-091941. Review. Erratum in: Br J Sports Med. 2013 Feb;47(3):184.

PMID:
23243113
18.

Biomarkers of susceptibility: State of the art and implications for occupational exposure to engineered nanomaterials.

Iavicoli I, Leso V, Schulte PA.

Toxicol Appl Pharmacol. 2016 May 15;299:112-24. doi: 10.1016/j.taap.2015.12.018. Epub 2015 Dec 24. Review.

PMID:
26724381
19.

Toxicogenomic approaches for understanding molecular mechanisms of heavy metal mutagenicity and carcinogenicity.

Koedrith P, Kim H, Weon JI, Seo YR.

Int J Hyg Environ Health. 2013 Aug;216(5):587-98. doi: 10.1016/j.ijheh.2013.02.010. Epub 2013 Mar 13. Review.

PMID:
23540489
20.

Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.

Stierum R, Heijne W, Kienhuis A, van Ommen B, Groten J.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):179-88. Review.

PMID:
16139318

Supplemental Content

Support Center